PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > Formulary Search > PAD Profile : Vardenafil - Penile rehabilitation
PAD Profile : Vardenafil - Penile rehabilitation
Keywords :
Phosphodiesterase type 5 inhibitors, ED, Impotence
Brand Names Include :
Levitra
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
Other Indications
Additional Documents
Type
Document
Review Date
Policy Statement
Erectile dysfunction oral and non oral combination treatments - Policy statement PCN 24-2012 - Jun 2
01 June 2025
Committee Recommendations
Date
Committee Name
Narrative
05 June 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
The Surrey Heartlands APC do not recommend vadenafil or avanafil for penile rehabilitation.
Sildenafil or tadalafil are the preferred options.
03 June 2020
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
At the Surrey and North-West Sussex Area Prescribing Committee (APC) held in June 2020, it was decided that all BLACK status drugs would have their review dates extended for 5 years without the need for a review.
If a clinician or provider wishes to change the traffic light status of any BLACK drug then they will need to submit a paper for change as per usual APC process.
03 June 2015
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
The PCN supports the use of sildenafil for penile rehabilitation. All other phosphodiesterase type-5 inhibitors (Viagra, avanafil, tadalafil and vardenafil) will be considered BLACK on the traffic light system.
Associated BNF Codes
07. Obstetrics, Gynaecology and Urinary-Tract Disorders
07.04.05. Drugs for erectile dysfunction